EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Hyperthyroidism in a 15-year-old adolescent treated with Dupilumab for severe allergic asthma and atopic dermatitis

Maria Angela Tosca, Roberta Olcese, Donata Girosi, Emilio Casalini, Marco Scaglione, Giorgio Ciprandi

Allergologia et Immunopathologia · 2023

DOI: 10.15586/aei.v51i3.786 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Allergologia et Immunopathologia, 2023. Verfasst von Maria Angela Tosca und 5 weiteren Autor:innen. Beteiligte Einrichtung: Allergy Clinic, IRCCS Giannina Gaslini, Genoa, Italy. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Asthma, Hypersensitivity, Hyperthyroidism. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dupilumab is a biologic, acting on IL-4 and IL-13 pathways. Dupilumab has a pediatric indication for treating severe asthma and atopic dermatitis. We report a pediatric case concerning paucisymptomatic, transient, and self-resolving hyperthyroidism. The updated literature includes the case of an adult patient who reported with hyperthyroidism, which was transient and self-resolving. Despite that these cases were transient and self-resolving, we would suggest that thyroid function assessment could be included in the follow-up of patients treated with Dupilumab. Dupilumab discontinuation is not required pending endocrinological assessment, mainly if there is an optimal clinical response to the biologic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicAsthmaHypersensitivityHyperthyroidismBiological ProductsAdultHumansAdolescentChildAntibodies, MonoclonalSeverity of Illness IndexTreatment OutcomeAntibodies, Monoclonal, Humanized

Stichwörter der Autor:innen

AsthmaAtopic DermatitisChildhoodDupilumabThyroid Function

Substanzen

Antibodies, MonoclonalBiological ProductsdupilumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Allergy Clinic, IRCCS Giannina Gaslini, Genoa, Italy.
  • Pediatric Pulmonology and Respiratory Endoscopy, IRCCS Giannina Gaslini, Genoa, Italy.
  • Pediatric Clinic and Endocrinology, IRCCS Giannina Gaslini, Genoa, Italy.
  • Allergy Clinic, Casa di Cura Villa Montallegro, Genoa, Italy; gio.cip@libero.it.

Zitieren

APA

Tosca, M. A., Olcese, R., Girosi, D., Casalini, E., Scaglione, M., & Ciprandi, G. (2023). Hyperthyroidism in a 15-year-old adolescent treated with Dupilumab for severe allergic asthma and atopic dermatitis. Allergologia et Immunopathologia. https://doi.org/10.15586/aei.v51i3.786

Vancouver

Tosca MA, Olcese R, Girosi D, Casalini E, Scaglione M, Ciprandi G. Hyperthyroidism in a 15-year-old adolescent treated with Dupilumab for severe allergic asthma and atopic dermatitis. Allergologia et Immunopathologia. 2023. doi:10.15586/aei.v51i3.786

BibTeX
@article{Tosca2023,
  author = {Tosca, Maria Angela and Olcese, Roberta and Girosi, Donata and Casalini, Emilio and Scaglione, Marco and Ciprandi, Giorgio},
  title = {Hyperthyroidism in a 15-year-old adolescent treated with Dupilumab for severe allergic asthma and atopic dermatitis},
  journal = {Allergologia et Immunopathologia},
  year = {2023},
  doi = {10.15586/aei.v51i3.786}
}
Kostenlos starten →